# A Study of LY900010 in Erectile Dysfunction

> **NCT01160289** · PHASE2 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 410 (actual)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DRUG:** LY2452473
- **DRUG:** tadalafil
- **DRUG:** placebo (tadalafil)
- **DRUG:** placebo (LY2452473)

## Key facts

- **NCT ID:** NCT01160289
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 410 (ACTUAL)
- **Last updated:** 2019-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01160289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01160289, "A Study of LY900010 in Erectile Dysfunction". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01160289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*